Cargando…

Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity

INTRODUCTION: Small cell lung cancer (SCLC) has recently been characterized as heterogeneous tumors due to consensus nomenclature for distinct molecular subtypes on the basis of differential expression of four transcription markers (ASCL1, NEUROD1, POU2F3, and YAP1). It is necessary to validate mole...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Jing, Zhang, Jiaqi, Liu, Ningbo, Zhao, Lujun, Xu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924463/ https://www.ncbi.nlm.nih.gov/pubmed/35311069 http://dx.doi.org/10.3389/fonc.2022.779276

Ejemplares similares

The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients
por: Qi, Jing, et al.
Publicado: (2021)

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022)

Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer
por: Zhu, Jiaqi, et al.
Publicado: (2022)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer
por: Zhang, Biao, et al.
Publicado: (2023)

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer
por: Daniello, Lea, et al.
Publicado: (2021)

Comprehensive Analysis of Immune Implication and Prognostic Value of IFI44L in Non-Small Cell Lung Cancer
por: Zeng, Yong, et al.
Publicado: (2022)

Practice Patterns of Treatment Strategy of Limited-Stage Small-Cell Lung Cancer: Survey of Chinese Oncologists
por: Xu, Chang, et al.
Publicado: (2022)

TGFβ1 in Cancer-Associated Fibroblasts Is Associated With Progression and Radiosensitivity in Small-Cell Lung Cancer
por: Zhang, Jiaqi, et al.
Publicado: (2021)

Histogram analysis of multi-model high-resolution diffusion-weighted MRI in breast cancer: correlations with molecular prognostic factors and subtypes
por: Qin, Yanjin, et al.
Publicado: (2023)

Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes
por: Mathias, Carolina, et al.
Publicado: (2021)

Prognostic Implication of the Expression Level of PECAM-1 in Non-small Cell Lung Cancer
por: Cao, Shuhui, et al.
Publicado: (2021)

CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes
por: Liu, Yi, et al.
Publicado: (2021)

Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
por: Li, Chenlu, et al.
Publicado: (2021)

Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
por: Kang, Zhen, et al.
Publicado: (2023)

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer
por: Su, Dan, et al.
Publicado: (2021)

Radiomics-Based Features for Prediction of Histological Subtypes in Central Lung Cancer
por: Li, Huanhuan, et al.
Publicado: (2021)

Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers
por: Chen, Hui, et al.
Publicado: (2022)

Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes
por: Lee, Suk Jun, et al.
Publicado: (2023)

CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer
por: Yuan, Li, et al.
Publicado: (2022)

Morphological Subtypes of Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: Prognostic Heterogeneity and Its Underlying Mechanism
por: Xie, Huikang, et al.
Publicado: (2021)

Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung Cancer
por: Wei, Yuanfeng, et al.
Publicado: (2023)

Optimizing Tissue Sampling for the Diagnosis, Subtyping, and Molecular Analysis of Lung Cancer
por: Ofiara, Linda Marie, et al.
Publicado: (2014)

Clinicopathological characteristics and features of molecular subtypes of breast cancer at high altitudes
por: Chen, Qi, et al.
Publicado: (2023)

Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer
por: Zhang, Xin, et al.
Publicado: (2019)

Computer-Aided Diagnosis Evaluation of the Correlation Between Magnetic Resonance Imaging With Molecular Subtypes in Breast Cancer
por: Meng, Wei, et al.
Publicado: (2021)

Characteristics and prognostic values of traditional pathological parameters and advanced molecular subtypes in women in Beijing with operable breast cancer: a retrospective analysis
por: Li, Qin, et al.
Publicado: (2018)

Molecular subtypes, clinical significance, and tumor immune landscape of angiogenesis-related genes in ovarian cancer
por: Tang, Haixia, et al.
Publicado: (2022)

Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer
por: Zhu, Jinhong, et al.
Publicado: (2020)

Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications
por: Joseph, Magdalene, et al.
Publicado: (2019)

The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer
por: Ordu, Cetin, et al.
Publicado: (2016)

Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer
por: Huang, Jianfeng, et al.
Publicado: (2022)

Molecular profiles of small cell lung cancer subtypes: therapeutic implications
por: Schwendenwein, Anna, et al.
Publicado: (2021)

Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients
por: Cai, Hai, et al.
Publicado: (2021)

Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer
por: Wang, Wenxian, et al.
Publicado: (2020)

The Machine Learning Model for Distinguishing Pathological Subtypes of Non-Small Cell Lung Cancer
por: Zhao, Hongyue, et al.
Publicado: (2022)

NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer
por: Cui, Yuehong, et al.
Publicado: (2021)

MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer
por: Li, Yike, et al.
Publicado: (2022)

FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers
por: Wang, Han, et al.
Publicado: (2022)

Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy
por: Feng, Dechao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qk8tsvgqp3h91ta1rrvf38jnhc